Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19. uri icon

authors

  • Glascock, Abigail
  • Kheradmand, Farrah
  • Baden, Lindsey R
  • Sekaly, Rafick
  • McComsey, Grace A
  • Haddad, Elias K
  • Cairns, Charles B
  • Geng, Linda N
  • Pulendran, Bali
  • Fernandez-Sesma, Ana
  • Simon, Viviana
  • Maguire, Cole
  • Metcalf, Jordan P
  • Agudelo Higuita, Nelson I
  • Messer, William B
  • Davis, Mark M
  • Nadeau, Kari C
  • Kraft, Monica
  • Bime, Christian
  • Erle, David J
  • Atkinson, Mark A
  • Scott Brakenridge, MD
  • Phan, Hoang Van
  • Ehrlich, Lauren I R
  • Montgomery, Ruth R
  • Shaw, Albert C
  • Hough, Catherine L
  • Hafler, David A
  • Augustine, Alison D
  • Becker, Patrice M
  • Peters, Bjoern
  • Ozonoff, Al
  • Hoch, Annmarie
  • Lydon, Emily C
  • Kim-Schulze, Seunghee
  • Krammer, Florian
  • Bosinger, Steven
  • Eckalbar, Walter
  • Altman, Matthew C
  • Wilson, Michael
  • Guan, Leying
  • Maecker, Holden
  • Steen, Hanno
  • Schaenman, Joanna
  • Diray-Arce, Joann
  • Rouphael, Nadine
  • Kleinstein, Steven H
  • Jayavelu, Naresh Doni
  • Reed, Elaine F
  • Levy, Ofer
  • Chu, Victoria T
  • Langelier, Charles R
  • Calfee, Carolyn S
  • Melamed, Esther
  • Greenland, John
  • Corry, David B

publication date

  • March 16, 2026